… We hypothesized that the association between IgM anti-PC and the risk of CV outcome is
different in the presence of CV risk factors. We therefore further performed analyses within the …

… and coronary occlusion is the leading underlying cause of myocardial infarction and sudden
cardiac … Autoantibodies directed towards a variety of oxidation-specific epitopes or self—…

… autoantibody (highest vs. lowest quartiles of autoantibody titer) on cardiovascular outcomes.
… the association between anti phosphorylcholine autoantibodies (anti-PC)- and CVD-related …

… could be related to the complexity of the LDL-oxidation process where antigens exposed
could vary to some extent, and there may also be differences in methods used for antibody …

… with the clinical outcomes. Potential immunomodulatory … antibody to target the root
causes of the inflammation and treat patients with early RA, thereby atherosclerosis and CVD…

… The present study highlights the potential of IgA antibody measurements to phosphocholine
as a new marker in CVD risk assessment and calls for additional studies on larger well-…

… We also divided patients into inflamed C-reactive protein (CRP) > 5·6 mg/ml and non-inflamed
CRP. Antibody levels were determined by in-house enzyme-linked immunosorbent assay. …

Atherosclerosis and its main consequence, cardiovascular disease (CVD) are nowadays
regarded as chronic inflammatory disease conditions, and CVD is the main cause of death in …

… The antibody levels were used for cases vs controls and cross-disease analysis. Statistical …
for each antibody. The correlation between antibody level and cardiovascular score (CV) was …

… Because experimental evidence indicates that these autoantibodies could per se promote …
fact that we did not assess other auto-antibodies of potential CV relevance, which is outside of …